Cardiovascular Risk After Adjuvant Trastuzumab in Early Breast Cancer: An Italian Population-Based Cohort Study.
Franchi M, Trama A, Merlo I, Minicozzi P, Tarantini L, Garau D, Kirchmayer U, Di Martino M, Romero M, De Carlo I, Scondotto S, Apolone G, Corrao G; FABIO working group.
Franchi M, et al. Among authors: di martino m.
Oncologist. 2020 Oct;25(10):e1492-e1499. doi: 10.1634/theoncologist.2020-0216. Epub 2020 Aug 29.
Oncologist. 2020.
PMID: 32770690
Free PMC article.